Document Detail

Effect of ranitidine on the antiplatelet effects of aspirin in healthy human subjects.
MedLine Citation:
PMID:  17196475     Owner:  NLM     Status:  MEDLINE    
Aspirin is often taken with H2-receptor antagonists. In vitro data suggest that certain antagonists, such as ranitidine, have inhibitory effects on platelet function. There are no reports on the combined effect of aspirin and H2-receptor antagonists on platelet function in humans. Therefore, this study's aim was to evaluate the effects of aspirin, ranitidine, and their combination on platelet function in humans. Ten healthy men aged 34.7 +/- 2 years received aspirin 325 mg/day for 4 days followed by a 9-day washout period, 3 days of ranitidine treatment (150 mg twice daily), and 4 days of dual-drug treatment. Blood samples were drawn at baseline and on the last days of aspirin monotherapy, the washout period, ranitidine monotherapy, and dual-drug treatment. Platelet aggregation was measured in response to 0.5 mg/ml arachidonic acid, 5 and 10 mumol/L adenosine diphosphate, and 1 micro g/ml collagen. The Platelet Function Analyzer 100 test was performed, and blood salicylate levels were measured in 6 subjects. Aspirin caused a marked reduction in platelet aggregation and prolongation of Platelet Function Analyzer 100 closure time. Ranitidine caused a modest decrease in platelet aggregation. Unexpectedly, the combination of aspirin and ranitidine caused less inhibition of platelet aggregation and prolongation of Platelet Function Analyzer 100 time than aspirin alone (p = 0.02 to 0.07 compared with aspirin alone). Blood salicylate levels were lower when subjects took aspirin with ranitidine than when they took aspirin alone (1 +/- 0.8 vs 1.6 +/- 0.7 mg/dl, p = 0.005). In conclusion, ranitidine appears to attenuate the antiplatelet effects of aspirin in healthy volunteers. The most likely mechanism for these findings is a change in the absorption conditions of aspirin in the presence of ranitidine.
Eli I Lev; Ramanujam S Ramabadran; Sasidhar Guthikonda; Rajnikant Patel; Amanda Kleiman; Juan F Granada; Timothy DeLao; Neal S Kleiman
Related Documents :
17008975 - The role of aspirin resistance on outcome in patients with acute coronary syndrome and ...
19543695 - Plasma salicylate level and aspirin resistance in survivors of myocardial infarction.
11745015 - Antithrombotic effect of geniposide and genipin in the mouse thrombosis model.
15882795 - Aspirin modulates lps-induced nitric oxide release in rat glial cells.
23609275 - Platelet activation and dysfunction in a large-animal model of traumatic brain injury a...
7892775 - Low platelet monoamine oxidase activity in pathological gambling.
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article     Date:  2006-11-09
Journal Detail:
Title:  The American journal of cardiology     Volume:  99     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2007 Jan 
Date Detail:
Created Date:  2007-01-01     Completed Date:  2007-02-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  124-8     Citation Subset:  AIM; IM    
The Methodist Hospital Research Institute and The Methodist DeBakey Heart Center, The Methodist Hospital, Houston, TX, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aspirin / administration & dosage,  pharmacology*
Blood Platelets / drug effects*
Drug Synergism
Drug Therapy, Combination
Histamine H2 Antagonists / administration & dosage,  pharmacology*
Platelet Aggregation / drug effects
Platelet Aggregation Inhibitors / administration & dosage,  pharmacology*
Ranitidine / administration & dosage,  pharmacology*
Reg. No./Substance:
0/Histamine H2 Antagonists; 0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin; 66357-35-5/Ranitidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Usefulness of time interval between end of diastolic mitral annular velocity pattern and onset of QR...
Next Document:  Mitral valve prolapse: now you see it; now you don't: recalling the discovery, rise and decline of a...